$1.62
-0.99 (-37.93%)
K V Pharmaceutical Co. Class A (NYSE:KV-A)
CAPS Rating:
Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.
RSS Headlines
Fool UK